Evidence map›Paper›PMID 29277199›Full record

ArticleThe lancet. Psychiatry2018

The Future of Psychiatry Commission.

Harris A Eyre, Arshya Vahabzadeh, Ryan Abbott, Ian A Cook, Michael Berk

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The lancet. Psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Harris A EyreInnovation Institute, Texas Medical Center, Houston, TX 77030, USA; IMPACT SRC, School of Medicine, Deakin University, Geelong, VIC, Australia; Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia; Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. Electronic address: Harris.eyre@gmail.com.
Arshya VahabzadehPsychiatry Academy, Massachusetts General Hospital, Boston, MA, USA; Brain Power, Cambridge, MA, USA.
Ryan AbbottSchool of Law, University of Surrey, Surrey, UK; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Ian A CookDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Neuromodulation Division and Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences at UCLA, Los Angeles, CA, USA.
Michael BerkDepartment of Psychiatry, University of Melbourne, Melbourne, VIC, Australia; Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia; Orygen The National Centre of Excellence in Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ForecastingPsychiatry

Identifiers

PMID29277199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.